Pradaxa 110 mg/1 (Dabigatran Etexilate PELLET) 110 mg/1

Pradaxa 110 mg pellets are an oral medication used for blood thinning. This guide covers uses, effects, and precautions for dabigatran etexilate.

Strength

110 mg/1

Pack Size

1 BAG in 1 CARTON (0597-0445-87) / 60 PELLET in 1 BAG

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pradaxa 110 mg pellets are primarily used to reduce the risk of blood clots and stroke in certain conditions. Dabigatran etexilate is often prescribed for atrial fibrillation or after hip/knee replacement surgery. This medication helps prevent clots by thinning the blood, which can be crucial for maintaining cardiovascular health.

Side Effects

Common effects of Pradaxa 110 mg pellets may include mild bleeding, bruising, or gastrointestinal discomfort. Some users report dizziness or nausea. Severe side effects, such as prolonged bleeding, are rare but require immediate medical attention.

Precautions & Warnings

Handle Pradaxa 110 mg pellets with care, especially if you have a history of bleeding disorders or kidney issues. Always follow your healthcare provider's instructions for safe usage. Store the medication as directed to maintain its effectiveness.

Avoid Interactions

Pradaxa 110 mg pellets can interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. Alcohol may increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Pradaxa 110 mg pellets are used to reduce the risk of blood clots and stroke in conditions like atrial fibrillation or after certain surgeries.

Pradaxa 110 mg pellets are taken orally, typically once or twice daily. Follow your healthcare provider's instructions for proper administration.

Common side effects may include mild bleeding, bruising, gastrointestinal discomfort, dizziness, or nausea.

Alcohol may increase the risk of bleeding while taking Pradaxa. Consult your healthcare provider for personalized advice.

If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.